Share Name Share Symbol Market Type Share ISIN Share Description
Shire Plc LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +76.00p +1.86% 4,156.50p 4,160.00p 4,161.50p 4,166.50p 4,079.00p 4,108.50p 3,607,497 16:35:16
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 9,229.1 393.7 34.8 125.3 24,632.41

Shire Share Discussion Threads

Showing 2076 to 2097 of 2100 messages
Chat Pages: 84  83  82  81  80  79  78  77  76  75  74  73  Older
DateSubjectAuthorDiscuss
21/7/2017
08:32
Figures Thursday,3 Aug .Might help to break the downtrend.
steeplejack
20/7/2017
21:06
Shire PLC (ADR) (SHPG) Hit 52-Week Low July 20, 2017 The stock of Shire PLC (ADR) (NASDAQ:SHPG) hit a new 52-week low and has $153.48 target or 4.00 % below today’s $159.87 share price. The 6 months bearish chart indicates high risk for the $47.93 billion company. The 1-year low was reported on Jul, 20 by Barchart.com. If the $153.48 price target is reached, the company will be worth $1.92 billion less. The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. HTTPS://finnewsdaily.com/shire-plc-adr-shpg-hit-52-week-low/
philanderer
20/7/2017
16:41
Much lower and this must surely be back on Pfizer or AbbVie's radar.
philanderer
20/7/2017
15:49
That`s weird , so why have Liberum got a 'hold' and 4900p target issued on tuesday 18th july ?
philanderer
20/7/2017
10:06
The shares have fallen through a support level identified at 4159p suggesting the shares could fall through 40 quid.Interesting to see how they close.Quite why the shares are so weak is puzzling.
steeplejack
19/7/2017
08:43
That's another low for 2017 , back to where we were a year ago now. edit: 19th july ShoreCap buy ... reiterates
philanderer
19/7/2017
00:19
The CEO of a $50 billion company explains why big-ticket dealmaking has dropped HTTP://uk.businessinsider.com/shire-ceo-flemming-ornskov-on-pharma-ma-2017-7
philanderer
18/7/2017
09:27
18th july Liberum hold tp 4900p reiterates
philanderer
17/7/2017
21:00
BTIG analyst, Timothy Chiang, reiterated his Buy rating on shares of Shire (NASDAQ: SHPG) and thinks the recent pressure on shares represents a buying opportunity. The analyst believes the competitive threat of Roche / Chugai's new monoclonal antibody, emicizumab (a new once-weekly subq injection for the treatment of hemophilia A), becoming a new treatment alternative for hemophilia patients, is already priced into the stock. Shire shares are now trading near their 52-week lows and the analyst believes the company should be proactive and announce a share repurchase. The analyst believes that the company has the potential to generate ~$15B in total revenue, with more than $6B of EBITDA. HTTPS://www.streetinsider.com/Analyst+Comments/Shire+plc+%28SHPG%29%3A+Pressure+Creates+Buying+Opportunity+-+BTIG/13102152.html
philanderer
17/7/2017
09:22
The only bu$$er down again in my portfolio :-)
philanderer
13/7/2017
18:01
Tomorrow maybe ? ;-) Friendless at the moment
philanderer
13/7/2017
15:21
I am a buyer at 4000
a2584728
13/7/2017
12:49
And down we go again :-S
philanderer
12/7/2017
09:00
12th july Soc Gen buy tp 7500p reiterates
philanderer
11/7/2017
17:12
Current US quote $160.58.... Stifel reiterated a Buy rating and $245.00 price target on Shire plc (NASDAQ: SHPG) following the International Society on Thrombosis and Hemostasis. Shire's competitor Roche unveiled data from its Phase 3 HAVEN 1 and 2 studies at the event. Roche reported unequivocally positive efficacy data for both its HAVEN 1 and 2 studies. HTTPS://www.streetinsider.com/Analyst+Comments/Stifel+Reiterates+Buy+on+Shire+plc+%28SHPG%29+Following+Competitor+Data+Release/13087170.html
philanderer
11/7/2017
14:14
am also surprised at the share price ftse down today though. thought the injunction against roche would have boosted it slightly but no dice
swedeee
11/7/2017
13:08
I think and hope the bottom is now and that include an oversold position it is a weary market and investor are all focusing of the potentially bad news and ignoring all the good ones generally mean buy opportunity for retail investor but too often retail suffer from hear symptoms and sell I more than double my investment today let hope I timed right excuse the poor English
jovi1
11/7/2017
12:48
Looks like 3500p is chart support.
philanderer
11/7/2017
10:18
Large cap pharmas are off some 10% in the last month.
steeplejack
11/7/2017
10:14
Where is the bottom of down trend .????
a2584728
11/7/2017
09:19
11th july JP Morgan Caz overweight tp 6000p reiterates
philanderer
10/7/2017
14:53
Downtrend now firmly in place.
philanderer
Chat Pages: 84  83  82  81  80  79  78  77  76  75  74  73  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170723 08:56:43